These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4715000)

  • 21. 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors.
    Wissner A; Berger DM; Boschelli DH; Floyd MB; Greenberger LM; Gruber BC; Johnson BD; Mamuya N; Nilakantan R; Reich MF; Shen R; Tsou HR; Upeslacis E; Wang YF; Wu B; Ye F; Zhang N
    J Med Chem; 2000 Aug; 43(17):3244-56. PubMed ID: 10966743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research on substances with antiblastic activity. LXII. Synthesis and antineoplastic activity of pyrrolo-[2,1-b] quinazoline derivatives and of 4H-pyrrolo[2,1-b] [1,3] benzodiazepine derivatives].
    Massa S; De Martino G
    Farmaco Sci; 1978 Apr; 33(4):271-80. PubMed ID: 738446
    [No Abstract]   [Full Text] [Related]  

  • 23. Derivatives of 2-hydroxy-p-phenetidine. I. Azomethines.
    Namkung MJ; Fletcher TL
    J Med Chem; 1970 Mar; 13(2):329. PubMed ID: 5418522
    [No Abstract]   [Full Text] [Related]  

  • 24. The development of HKI-272 and related compounds for the treatment of cancer.
    Wissner A; Mansour TS
    Arch Pharm (Weinheim); 2008 Aug; 341(8):465-77. PubMed ID: 18493974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
    Hatheway GJ; Hansch C; Kim KH; Milstein SR; Schmidt CL; Smith RN; Quinn FR
    J Med Chem; 1978 Jun; 21(6):563-74. PubMed ID: 671453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synthesis and antimalarial as well as antitumor activities of 2,4-diamino-6-(N-methyl-substituted benzylamino) quinazolines].
    Zhou WC; Li GY; Xin ZM; Li BS; Chen GD; Dai ZR; Zhang XP
    Yao Xue Xue Bao; 1989; 24(2):99-104. PubMed ID: 2678893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure-activity relationships of 3-cyano-4-(phenoxyanilino)quinolines as MEK (MAPKK) inhibitors.
    Zhang N; Wu B; Powell D; Wissner A; Floyd MB; Kovacs ED; Toral-Barza L; Kohler C
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2825-8. PubMed ID: 11133101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
    Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticancer compounds. Further analogs of 1-(4-dimethylaminobenzylidene)indene.
    Bahner CT; Bingham NH; Brotherton DH; Cline J; Darby D; Harmon HD; Rives LM; Stump BL; Watson SL
    J Med Chem; 1973 Apr; 16(4):421-5. PubMed ID: 4716189
    [No Abstract]   [Full Text] [Related]  

  • 30. Potential antitumor agents. 31. Quantitative structure-activity relationships for the antileukemic bis(guanylhydrazones).
    Denny WA; Cain BF
    J Med Chem; 1979 Oct; 22(10):1234-8. PubMed ID: 513070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of novel 2,3-dihydro-1,4-dioxino[2,3-g]quinoline derivatives as potential antitumor agents.
    Vázquez MT; Romero M; Pujol MD
    Bioorg Med Chem; 2004 Mar; 12(5):949-56. PubMed ID: 14980607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commentary. The role of structure-activity studies in the design of antitumor agents.
    Cain BF
    Cancer Chemother Rep; 1975; 59(4):679-83. PubMed ID: 1175161
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis and biological activity of some antitumor benzophenanthridinium salts.
    Stermitz FR; Gillespie JP; Amoros LG; Romero R; Stermitz TA; Larson KA; Earl S; Ogg JE
    J Med Chem; 1975 Jul; 18(7):708-13. PubMed ID: 1097692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential antitumor agents: procarbazine analogs and other methylhydrazine derivatives.
    Beisler JA; Peng GW; Driscoll JS
    J Pharm Sci; 1977 Jun; 66(6):849-52. PubMed ID: 874788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and antitumor activity of derivatives of 1-phenyl-3,3-dimethyltriazene.
    Lin YT; Loo TL
    J Med Chem; 1972 Feb; 15(2):201-3. PubMed ID: 5008242
    [No Abstract]   [Full Text] [Related]  

  • 36. Sycnthesis of quinazoline analogues of folic acid modified at postion 10.
    Oatis JE; Hynes JB
    J Med Chem; 1977 Nov; 20(11):1393-6. PubMed ID: 915899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterocyclic Quinones. 4. A new highly cytotoxic drug: 6,7-bis(1-aziridinyl)-5,8-quinazolinedione.
    Renault J; Giorgi-Renault S; Baron M; Mailliet P; Paoletti C; Cros S; Voisin E
    J Med Chem; 1983 Dec; 26(12):1715-9. PubMed ID: 6644740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential antitumor agents. 14. Acridylmethanesulfonanilides.
    Cain BF; Seelye RN; Atwell GJ
    J Med Chem; 1974 Sep; 17(9):922-30. PubMed ID: 4415157
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytotoxic activity of the selected pyridinium salts against murine leukemia L1210.
    Wieczorkowska M; Szajerski P; Michalski R; Adamus J; Marciniak A; Gebicki J; Ciesielska E; Szmigiero L; Lech-Marańda E; Szmigielska-Kapłon A; Robak T
    Pharmacol Rep; 2007; 59(2):216-23. PubMed ID: 17556800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antitumour activity of ZD9331, a non-polyglutamatable quinazoline thymidylate synthase inhibitor.
    Jackman AL; Kimbell R; Brown M; Brunton L; Harrap KR; Wardleworth JM; Boyle FT
    Adv Exp Med Biol; 1994; 370():185-8. PubMed ID: 7660886
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.